Multivalent nanomaterials: learning from vaccines and progressing to antigen-specific immunotherapies

Area of Science:

• Immunology
• Materials Science
• Nanotechnology

Background:

• Vaccine design utilizes multivalent antigen presentation to enhance immunogenic responses.
• Multivalent nanomaterials are now explored for inducing immune tolerance in autoimmune diseases and allergies.
• Traditional vaccines combine antigen with adjuvant to amplify immune responses.

Purpose of the Study:

• To review the role of multivalent ligand display on linear polymers for directing immune responses.
• To explore the interplay of physical parameters in multivalent nanomaterial design.
• To highlight molecular and transport mechanisms influencing immune outcomes.

Main Methods:

• Analysis of soluble, linear polymers with tailored length, ligand valency, and density.
• Incorporation of secondary signals to modulate immune responses.
• Consideration of nanomaterial biodistribution and transport mechanisms.

Main Results:

• Soluble linear polymers can direct antigen-specific immunogenicity or tolerance.
• Modulating polymer length, ligand valency, and density influences immune outcomes.
• Codelivery of secondary signals can direct, amplify, or suppress immune responses.

Conclusions:

• Multivalent nanomaterials offer advanced antigen-specific immunotherapies.
• Physical properties and ligand display critically influence immune response direction.
• Both molecular and transport mechanisms are key to controlling immune responses with nanomaterials.